0000874015-13-000008.txt : 20130103 0000874015-13-000008.hdr.sgml : 20130103 20130103210028 ACCESSION NUMBER: 0000874015-13-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130102 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOUGEN ELIZABETH L CENTRAL INDEX KEY: 0001074773 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 13509563 MAIL ADDRESS: STREET 1: 10070 BARNES CANYON ROAD STREET 2: C/O MOLECULAR BIOSYSTEMS INC CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-01-02 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001074773 HOUGEN ELIZABETH L C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 SVP, Finance and CFO Employee Stock Option (right to buy) 10.82 2013-01-02 2013-01-02 4 A 0 7500 0 A 2020-01-01 Common Stock 7500 7500 D Employee Stock Option (right to buy) 10.82 2013-01-02 2013-01-02 4 A 0 15700 0 A 2020-01-01 Common Stock 15700 15700 D Grant of 1/2/13 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/14. Thereafter, the remaining shares subject to the option vest and become exerciable in 36 equal monthly installments, at the rate of 1,875 shares per year. The option is exercisable as to 0 on 1/1/13. Grant of 1/2/13 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/14. Thereafter, the remaining shares subject to the option vest and become exerciable in 36 equal monthly installments, at the rate of 3,925 shares per year. The option is exercisable as to 0 on 1/2/13. /s/Elizabether L. Hougen 2013-01-02